Genetics and dynamics of the immune response to HTLV-I

Gann Monographs on Cancer Research

Volumn 50, Issue , 2003, Pages 149-170

  Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GENOMIC DNA; HLA A ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; LAMIVUDINE; MESSENGER RNA; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR; TAX PROTEIN; VIRUS PROTEIN; ZIDOVUDINE;

ALLELE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 ASSOCIATED MYELOPATHY; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; RISK FACTOR; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TISSUE INJURY; VIRUS CARRIER; VIRUS GENOME; VIRUS INHIBITION; VIRUS LATENCY; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION;

EID: 0041788246     PISSN: 00720151     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (75)

1. Asquith, B. and Bangham, C. R. The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J. Theor. Biol., 207, 65-79 (2000).
2. Asquith, B., Hanon, E., Taylor, G. P., and Bangham, C. R. Is human T-cell lymphotropic virus type I really silent? Philos. Trans. R. Soc. Lond. B Biol. Sci., 355, 1013-1019 (2000).
3. Bangham, C. R. The immune response to HTLV-I. Curr. Opin. Immunol., 12, 397-402 (2000).
4. Bangham, C. R. M., Kermode, A. G., Hall, S. E., and Daenke, S. The cytotoxic T-lymphocyte response to HTEV-I: the main determinant of disease? Semin. Virol., 7, 41-48 (1996).
5. Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., and Picker, E. J. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol., 75, 11983-11991 (2001).
6. Biddison, W. E., Kubota, R., Kawanishi, T., Taub, D. D., Cruikshank, W. W., Center, D. M., Connor, E. W., Utz, U., and Jacobson, S. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J. Immunol., 159, 2018-2025 (1997).
7. Bieganowska, K., Hollsberg, F., Buckle, G. J., Lim, D. G., Greten, T. F., Schneck, J., Altman, J. D., Jacobson, S., Ledis, S. L., Hanchard, B., Chin, J., Morgan, O., Roth, P. A., and Hafler, D. A. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol., 162, 1765-1771 (1999).
8. Cavrois, M., Gessain, A., Wain-Hobson, S., and Wattel, E. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene, 12, 2419-2423 (1996).
9. Cho, I., Sugimoto, M., Mita, S., Tokunaga, M., Imamura, F., and Ando, M. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. Am. J. Trop. Med. Hyg., 53, 412-418 (1995).
10. Daenke, S., Kermode, A. G., Hall, S. E., Taylor, G., Weber, J., Nightingale, S., and Bangham, C. R. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology, 217, 139-146 (1996).
11. Daenke, S., Nightingale, S., Cruickshank, J. K., and Bangham, C. R. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J. Virol., 64, 1278-1282 (1990).
12. Derse, D., Hill, S. A., Lloyd, P. A., Chung, H., and Morse, B. A. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J. Virol., 75, 8461-8468 (2001).
13. Eiraku, N., Ijichi, S., Yashiki, S., Osame, M., and Sonoda, S. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP). J. Neuroimmunol., 37, 223-228 (1992).
14. Elovaara, I., Koenig, S., Brewah, A. Y., Woods, R. M., Lehky, T., and Jacobson, S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med., 177, 1567-1573 (1993).
15. Furukawa, Y., Yamashita, M., Usuku, K., Izumo, S., Nakagawa, M., and Osame, M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis., 182, 1343-1349 (2000).
16. Goon, P. K. C., Hanon, E., Igakura, T., Tanaka, Y., Weber, J. N., Taylor, G. P., and Bangham, C. R. M. High frequencies of Th1 type CD4+ T-cells specific to HTLV-I Env and Tax proteins in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Blood, 99, 3335-3341 (2002).
17. Greten, T. F., Slansky, J. E., Kubota, R., Soldan, S. S., Jaffee, E. M., Leist, T. P., Pardoll, D. M., Jacobson, S., and Schneck, J. P. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. USA, 95, 7568-7573 (1998).
18. Hanon, E., Goon, P., Taylor, G. P., Hasegawa, H., Tanaka, Y., Weber, J. N., and Bangham, C. R. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood, 98, 721-726 (2001).
19. Hanon, E., Hall, S., Taylor, G. P., Saito, M., Davis, R., Tanaka, Y., Usuku, K., Osame, M., Weber, J. N., and Bangham, C. R. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood, 95, 1386-1392 (2000).
20. Hanon, E., Stinchcombe, J. C., Saito, M., Asquith, B. E., Taylor, G. P., Tanaka, Y., Weber, J. N., Griffiths, G. M., and Bangham, C. R. Fratricide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity, 13, 657-664 (2000).
21. Hollsberg, P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol. Mol. Biol. Rev., 63, 308-333 (1999).
22. Horiuchi, I., Kawano, Y., Yamasaki, K., Minohara, M., Furue, M., Taniwaki, T., Miyazaki, T., and Kira, J. Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis. J. Neurol. Sci., 172, 17-24 (2000).
23. Huang, J. F., Yang, Y., Sepulveda, H., Shi, W., Hwang, I., Peterson, P. A., Jackson, M. R., Sprent, J., and Cai, Z. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science, 286, 952-954 (1999).
24. Inoue, J., Seiki, M., Taniguchi, T., Tsuru, S., and Yoshida, M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J., 5, 2883-2888 (1986).
25. Iwasaki, Y., Ohara, Y., Kobayashi, I., and Akizuki, S. Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am. J. Pathol., 140, 1003-1008 (1992).
26. Jacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S., and Koenig, S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature, 348, 245-248 (1990).
27. Jeffery, K. J., Siddiqui, A. A., Bunce, M., Lloyd, A. L., Vine, A. M., Witkover, A. D., Izumo, S., Usuku, K., Welsh, K. I., Osame, M., and Bangham, C. R. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol., 165, 7278-7284 (2000).
28. Jeffery, K. J., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., Lloyd, A. L., Nowak, M. A., Nagai, M., Kodama, D., Izumo, S., Osame, M., and Bangham, C. R. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA, 96, 3848-3853 (1999).
29. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R. M., and Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol., 14, 207-232 (1996).
30. Kannagi, M., Harada, S., Maruyama, I., Inoko, H., Igarashi, H., Kuwashima, G., Sato, S., Morita, M., Kidokoro, M., Sugimoto, M. et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol., 3, 761-767 (1991).
31. Kannagi, M., Sugamura, K., Kinoshita, K., Uchino, H., and Hinuma, Y. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J. Immunol., 133, 1037-1041 (1984).
32. Kannagi, M., Sugamura, K., Sato, H., Okochi, K., Uchino, H., and Hinuma, Y. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. J. Immunol., 130, 2942-2946 (1983).
33. Kazanji, M., Moreau, J. P., Mahieux, R., Bonnemains, B., Bomford, R., Gessain, A., and de The, G. HTLV-I infection in squirrel monkeys (Saimiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines. Virology, 231, 258-266 (1997).
34. Kitze, B., Usuku, K., Yamano, Y., Yashiki, S., Nakamura, M., Fujiyoshi, T., Izumo, S., Osame, M., and Sonoda, S. Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. Clin. Exp. Immunol., 111, 278-285 (1998).
35. Koyanagi, Y., Itoyama, Y., Nakamura, N., Takamatsu, K., Kira, J., Iwamasa, T., Goto, I., and Yamamoto, N. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology, 196, 25-33 (1993).
36. Kubota, R., Kawanishi, T., Matsubara, H., Manns, A., and Jacobson, S. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J. Neuroimmunol., 102, 208-215 (2000).
37. Lal, R. B., Rudolph, D. L., Dezzutti, C. S., Linsley, P. S., and Prince, H. E. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands. J. Immunol., 157, 1288-1296 (1996).
38. Lin, Y. L. and Askonas, B. A. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J. Exp. Med., 154, 225-234 (1981).
39. Macallan, D. C., Fullerton, C. A., Neese, R. A., Haddock, K., Park, S. S., and Hellerstein, M. K. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc. Natl. Acad. Sci. USA, 95, 708-713 (1998).
40. Manns, A., Murphy, E. L., Wilks, R., Haynes, G., Figueroa, J. P., Hanchard, B., Barnett, M., Drummond, J., Waters, D., Cerney, M. et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood, 77, 896-905 (1991).
41. Matsuzaki, T., Nakagawa, M., Nagai, M., Usuku, K., Higuchi, I., Arimura, K., Kubota, H., Izumo, S., Akiba, S., and Osame, M. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J. Neurovirol., 7, 228-234 (2001).
42. McMichael, A. J. (1995). Immunology. In "Oxford Textbook of Medicine," 3rd Ed., ed. D. J. Weatherall, J. G. G. Ledingham, and D. A. Warrell (1995). Oxford University Press, Oxford.
43. Moritoyo, T., Izumo, S., Moritoyo, H., Tanaka, Y., Kiyomatsu, Y., Nagai, M., Usuku, K., Sorimachi, M., and Osame, M. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J. Neurovirol., 5, 241-248 (1999).
44. Mortreux, F., Kazanji, M., Gabet, A. S., de Thoisy, B., and Wattel, E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J. Virol., 75, 1083-1089 (2001).
45. Mueller, N. E. and Blattner, W. A. Retroviruses. In "Viral Infections of Humans: Epidemiology and Control," 4th Ed., ed. A. S. Evans and R. Kaslow, pp. 785-813 (1997). Plenum Medical Press, New York.
46. Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., and Osame, M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol., 4, 586-593 (1998).
47. Nei, M. and Gojobori, T Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol., 3, 418-426 (1986).
48. Niewiesk, S. and Bangham, C. R. Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis. J. Mol. Evol., 42, 452-458 (1996).
49. Niewiesk, S., Daenke, S., Parker, C. E., Taylor, G., Weber, J., Nightingale, S., and Bangham, C. R. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol., 68, 6778-6781 (1994).
50. Niewiesk, S., Daenke, S., Parker, C. E., Taylor, G., Weber, J., Nightingale, S., and Bangham, C. R. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol., 69, 2649-2653 (1995).
51. Nowak, M. A. and Bangham, C. R. Population dynamics of immune responses to persistent viruses. Science, 272, 74-79 (1996).
52. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., Hurley, A., Markowitz, M., Ho, D. D., Nixon, D. F., and McMichael, A. J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science, 279, 2103-2106 (1998).
53. Ogg, G. S. and McMichael, A. J. HLA-peptide tetrameric complexes. Curr. Opin. Immunol., 10, 393-396 (1998).
54. Oka, T., Ohtsuki, Y., Sonobe, H., Furihata, M., and Miyoshi, I. Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I). Arch. Virol., 115, 63-73 (1990).
55. Overbaugh, J. and Bangham, C. R. Selection forces and constraints on retroviral sequence variation. Science, 292, 1106-1109 (2001).
56. Oxenius, A., Zinkernagel, R. M., and Hengartner, H. CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. Adv. Immunol., 70, 313-367 (1998).
57. Parker, C. E., Daenke, S., Nightingale, S., and Bangham, C. R. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology, 188, 628-636 (1992).
58. Parker, C. E., Nightingale, S., Taylor, G. P., Weber, J., and Bangham, C. R. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol., 68, 2860-2868 (1994).
59. Raftery, M. J., Behrens, C. K., Muller, A., Krammer, P. H., Walczak, H., and Schonrich, G. Herpes simplex virus type 1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med., 190, 1103-1114 (1999).
60. Smith, M. R. and Greene, W. C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev., 4, 1875-1885 (1990).
61. Taylor, G. P, Hall, S. E., Navarrete, S., Michie, C. A., Davis, R., Witkover, A. D., Rossor, M., Nowak, M. A., Rudge, P., Matutes, E., Bangham, C. R., and Weber, J. N. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J. Virol., 73, 10289-10295 (1999).
62. Townsend, A. and Bodmer, H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol., 7, 601-624 (1989).
63. Townsend, A. R., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D., and McMichael, A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell, 44, 959-968 (1986).
64. Usuku, K., Nishizawa, M., Matsuki, K., Tokunaga, K., Takahashi, K., Eiraku, N., Suehara, M., Juji, T., Osame, M., and Tabira, T. Association of a particular amino acid sequence of the HLA-DR beta 1 chain with HTLV-I-associated myelopathy. Eur. J. Immunol., 20, 1603-1606 (1990).
65. Usuku, K., Sonoda, S., Osame, M., Yashiki, S., Takahashi, K., Matsumoto, M., Sawada, T., Tsuji, K., Tara, M., and Igata, A. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol., 23, S143-S150 (1988).
66. Valitutti, S., Muller, S., Dessing, M., and Lanzavecchia, A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med., 183, 1917-1921 (1996).
67. Vine, A. M., Witkover, A. D., Lloyd, A. L., Jeffery, K. J. M., Siddiqui, A., Marshall, S. E. F., Bunce, M., Eiraku, N., Izumo, S., Usuku, K., Osame, M., and Bangham, C. R. M. Polygenic control of HTLV-I proviral load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J. Infect. Dis., 186, 932-939 (2002).
68. Wodarz, D. and Bangham, C. R. Evolutionary dynamics of HTLV-I. J. Mol. Evol., 50, 448-455 (2000).
69. Wodarz, D., Hall, S. E., Usuku, K., Osame, M., Ogg, G. S., McMichael, A. J., Nowak, M. A., and Bangham, C. R. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc. R. Soc. Lond. B Biol. Sci., 268, 1215-1221 (2001).
70. Wodarz, D., Nowak, M. A., and Bangham, C. R. The dynamics of HTLV-I and the CTL response. Immunol. Today, 20, 220-227 (1999).
71. Wucherpfennig, K. W., Hollsberg, P., Richardson, J. H., Benjamin, D., and Hafler, D. A. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc. Natl. Acad. Sci. USA, 89, 2110-2114 (1992).
72. Yamano, Y., Kitze, B., Yashiki, S., Usuku, K., Fujiyoshi, T., Kaminagayoshi, T., Unoki, K., Izumo, S., Osame, M., and Sonoda, S. Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis). J. Neuroimmunol., 76, 50-60 (1997).
73. Yoshida, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol., 19, 475-496 (2001).
74. Yu, F., Itoyama, Y., Fujihara, K., and Goto, I. Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals. J. Neuroimmunol., 33, 121-128 (1991).
75. Zinkernagel, R. M. and Hengartner, H. Antiviral immunity. Immunol. Today, 18, 258-260 (1997).